💊

Thiotepa Riemser

thiotepa

Hematopoëtische stamceltransplantatie; neoplasmata

✅ Geautoriseerd Algemeen

✅

Geen actieve meldingen

Dit geneesmiddel heeft geen lopende tekorten, veiligheidsbrieven of terugroepacties.

Waarvoor het wordt gebruikt

Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients. Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients

⚠️ Patiëntveiligheid

Officiële EMA-pagina

https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser